Aminothiazole compounds substituted with sulfur-containing groups are represented by the Formula (I), and their pharmaceutically acceptable salts, prodrugs, active metabolites, and pharmaceutically acceptable salts of said metabolites are described.
1
These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.
含有
硫基取代的
氨基
噻唑化合物的
化学式为(I),其药物可接受的盐、前药、活性代谢物和药物可接受的代谢物的描述如下。这些药物可以调节和/或抑制细胞增殖和蛋白激酶活性,是治疗恶性肿瘤和其他疾病的药物。